机构：[1]Institute of Nephrology and Blood Purification, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China[2]Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine,Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s Hospital, Shenzhen, Guangdong 518020, China深圳市人民医院深圳医学信息中心[3]Guangxi Key Laboratory of Metabolic Diseases Research, Affiliated No. 924 Hospital, Southern Medical University, Guilin 541002, China[4]The Second People’s Hospital of Lianping County, Heyuan 517139, Guangdong, China[5]Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine, Dongguan 523000, Guangdong, China
Key Renal Laboratory of
Shenzhen (grant number ZDSYS2015430161623417), the
Guangxi Key Laboratory of Metabolic Diseases Research
(grant number 20-065-76), the Science and Technology Plan
of Shenzhen (grant number JCYJ20190807153405508), the
Guangdong Provincial High-level Clinical Key Specialties
(grant number SZGSP001), the Natural Science Foundation
of Guangxi (grant number 2017GXNSFAA198185), the
Science and Technology Plan of Shenzhen (grant number
JCYJ201803 06140810282), the Key Research and Development
Program of Guangdong Province (grant number
2019B020229001), and 2019 Dongguan Social Science and
Technology Development (key) project (grant number
201950715002195).
第一作者机构：[1]Institute of Nephrology and Blood Purification, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510632, China[2]Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine,Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s Hospital, Shenzhen, Guangdong 518020, China
通讯作者：
通讯机构：[2]Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine,Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s Hospital, Shenzhen, Guangdong 518020, China[3]Guangxi Key Laboratory of Metabolic Diseases Research, Affiliated No. 924 Hospital, Southern Medical University, Guilin 541002, China[5]Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine, Dongguan 523000, Guangdong, China[*1]Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine, Dongguan 523000, Guangdong, China[*2]Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s Hospital, Shenzhen, Guangdong 518020, China[*3]Guangxi Key Laboratory of Metabolic Diseases Research, Affiliated No. 924 Hospital, Southern Medical University, Guilin 541002, China
推荐引用方式(GB/T 7714)：
Dong Jingjing,Li Yixi,Zheng Fengping,et al.Co-occurrence of Protein Crotonylation and 2-Hydroxyisobutyrylation in the Proteome of End-Stage Renal Disease.[J].ACS OMEGA.2021,6(24):15782-15793.doi:10.1021/acsomega.1c01161.
APA：
Dong Jingjing,Li Yixi,Zheng Fengping,Chen Wenbiao,Huang Shaoying...&Dai Yong.(2021).Co-occurrence of Protein Crotonylation and 2-Hydroxyisobutyrylation in the Proteome of End-Stage Renal Disease..ACS OMEGA,6,(24)
MLA：
Dong Jingjing,et al."Co-occurrence of Protein Crotonylation and 2-Hydroxyisobutyrylation in the Proteome of End-Stage Renal Disease.".ACS OMEGA 6..24(2021):15782-15793
